bioAffinity Technologies, Inc. Increase (Decrease) in Prepaid Expense and Other Assets
bioAffinity Technologies, Inc. (BIAF) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$57.66 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-07
- bioAffinity Technologies, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$17.66K.
- bioAffinity Technologies, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$40.00K.
- bioAffinity Technologies, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $59.73K.
- bioAffinity Technologies, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $60.04K, a 67.77% decline year-over-year.
- bioAffinity Technologies, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $90.06K, a 14.71% decline from fiscal 2024.
- bioAffinity Technologies, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $105.59K.
- bioAffinity Technologies, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$214.40K, a 143.51% decline from fiscal 2022.
- bioAffinity Technologies, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $492.75K, a 1308.27% increase from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$17.66K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$57.66K 10-Q · filed 2026-08-07 | $2.07K derived: sum of 3 quarters · filed 2026-08-07 | $62.10K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | -$40.00K 10-Q · filed 2026-05-11 | $19.73K derived: sum of 2 quarters · filed 2026-05-11 | $79.76K derived: sum of 3 quarters · filed 2026-05-11 | $56.50K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $59.73K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $119.77K derived: sum of 2 quarters · filed 2026-03-16 | $96.51K derived: sum of 3 quarters · filed 2026-08-07 | $90.06K 10-K · filed 2026-03-16 |
| 2025-09-30 | $60.04K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $36.78K derived: sum of 2 quarters · filed 2026-08-07 | $30.33K 10-Q · filed 2025-11-14 | $13.30K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | -$23.26K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$29.71K 10-Q · filed 2026-08-07 | -$46.74K derived: sum of 3 quarters · filed 2026-08-07 | $139.56K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | -$6.45K 10-Q · filed 2026-05-11 | -$23.48K derived: sum of 2 quarters · filed 2026-05-11 | $162.82K derived: sum of 3 quarters · filed 2026-05-11 | $75.27K derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | -$17.03K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $169.27K derived: sum of 2 quarters · filed 2026-03-16 | $81.71K derived: sum of 3 quarters · filed 2026-03-16 | $105.59K 10-K · filed 2026-03-16 |
| 2024-09-30 | $186.30K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $98.74K derived: sum of 2 quarters · filed 2025-11-14 | $122.63K 10-Q · filed 2025-11-14 | $60.99K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | -$87.56K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$63.68K 10-Q · filed 2025-08-14 | -$125.31K derived: sum of 3 quarters · filed 2025-08-14 | -$26.79K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $23.88K 10-Q · filed 2025-05-15 | -$37.75K derived: sum of 2 quarters · filed 2025-05-15 | $60.77K derived: sum of 3 quarters · filed 2025-05-15 | -$100.67K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | -$61.63K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $36.89K derived: sum of 2 quarters · filed 2025-03-31 | -$124.56K derived: sum of 3 quarters · filed 2025-03-31 | -$214.40K 10-K · filed 2025-03-31 |
| 2023-09-30 | $98.52K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$62.92K derived: sum of 2 quarters · filed 2024-11-14 | -$152.77K 10-Q · filed 2024-11-14 | -$162.19K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | -$161.44K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$251.29K 10-Q · filed 2024-08-14 | -$260.72K derived: sum of 3 quarters · filed 2024-08-14 | $269.76K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | -$89.85K 10-Q · filed 2024-05-15 | -$99.27K derived: sum of 2 quarters · filed 2024-05-15 | $431.21K derived: sum of 3 quarters · filed 2024-05-15 | $414.05K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | -$9.42K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $521.06K derived: sum of 2 quarters · filed 2024-04-01 | $503.90K derived: sum of 3 quarters · filed 2024-04-01 | $492.75K 10-K · filed 2024-04-01 |
| 2022-09-30 | $530.48K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $513.32K derived: sum of 2 quarters · filed 2023-11-14 | $502.18K 10-Q · filed 2023-11-14 | $485.41K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | -$17.16K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$28.30K 10-Q · filed 2023-08-14 | -$45.07K derived: sum of 3 quarters · filed 2023-08-14 | |
| 2022-03-31 | -$11.14K 10-Q · filed 2023-05-15 | -$27.91K derived: sum of 2 quarters · filed 2023-05-15 | ||
| 2021-12-31 | -$16.77K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $34.99K 10-K · filed 2023-03-31 | ||
| 2021-09-30 | $51.76K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |